Biotika A.S. Logo

Biotika A.S.

Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.

BSL | BSSE

Overview

Corporate Details

ISIN(s):
SK1120004009
LEI:
097900BGMP0000060091
Country:
Slovakia
Address:
566, 976 13 Slovenská Ľupča
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Biotika A.S. is a Slovak biotechnology company and manufacturer of Active Pharmaceutical Ingredients (APIs) with a tradition spanning over 70 years. The company specializes in the biotechnological production of APIs, with its main products being penicillin and polymyxin B sulfate for both human and veterinary applications. In addition to its core production, Biotika offers contract manufacturing services, including the transfer and scaling of biotechnological products from laboratory to commercial production. The company is also engaged in research and development within the field of biotechnology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-24 11:04
Post-Annual General Meeting Information
Uznesenia z RVZ Biotika a.s. z 18.6.2025
Slovak 85.4 KB
2025-05-16 08:20
Pre-Annual General Meeting Information
Oznámenie o konaní VZ dňa 18.6.2025
Slovak 126.3 KB
2025-04-30 11:55
Report Publication Announcement
Inzercia v HN Ročná finančná správa 2024
Slovak 631.5 KB
2025-01-30 15:19
Post-Annual General Meeting Information
Uznesenia z MVZ Biotika a.s. z 29.1.2025
Slovak 178.9 KB
2024-12-20 13:16
Pre-Annual General Meeting Information
Oznámenie o konaní MVZ dňa 29.1.2025
Slovak 51.0 KB
2024-12-19 08:50
Declaration of Voting Results & Voting Rights Announcements
Zmena podielu na hlasovacích právach emitenta
Slovak 1.2 MB
2024-04-12 13:57
Post-Annual General Meeting Information
Uznesenia z RVZ Biotika a.s. z 11.4.2024
Slovak 135.0 KB
2024-03-11 15:24
Pre-Annual General Meeting Information
Oznámenie o konaní VZ dňa 11.4.2024
Slovak 153.0 KB
2024-01-31 12:08
Declaration of Voting Results & Voting Rights Announcements
Biotika zmeny v podieloch na hlasovacích právach
Slovak 157.3 KB
2024-01-18 11:48
Interim Report
Polročná finančná správa 2023 doplnenie
Slovak 303.6 KB
2023-08-23 13:49
Declaration of Voting Results & Voting Rights Announcements
Oznámenie o zmene hlasovacích práv
Slovak 60.2 KB
2023-08-22 14:56
Major Shareholding Notification
Oznámenie o nadobudnutí hlasovacích práv - Vinohrady Investments, a.s.
Slovak 525.0 KB
2023-08-22 14:55
Declaration of Voting Results & Voting Rights Announcements
Oznámenie o prevode hlasovacích práv - BIO S.L., a.s.
Slovak 511.8 KB
2023-03-31 13:54
Post-Annual General Meeting Information
Uznesenia z RVZ Biotika a.s. z 30.3.2023
Slovak 596.2 KB
2023-02-27 10:55
Pre-Annual General Meeting Information
Oznámenie o konaní VZ dňa 30.3.2023
Slovak 151.9 KB

Automate Your Workflow. Get a real-time feed of all Biotika A.S. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Biotika A.S. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.